外显子组测序在孤立性胎儿生长受限中的诊断率:系统综述与Meta分析
本系统综述与Meta分析纳入8项研究、146例孤立性胎儿生长受限且染色体微阵列分析或核型分析阴性的胎儿,评估外显子组测序的增量诊断率;结果17例检出可能致病的致病性变异,合并增量诊断率为12%(95%CI:7%-18%),绝大多数胎儿在32周前被评估。
要点
- 孤立性胎儿生长受限且CMA或核型分析阴性时,外显子组测序增量诊断率为12%(95%CI:7%-18%)。
- 146例中17例检出可能解释胎儿表型的致病性变异。
- 纳入研究的胎儿绝大多数在32周前接受评估。
核心结论
- 在表型为孤立性胎儿生长受限的胎儿中,12%产前发现与单基因病相关的致病性变异。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,纳入仅含无胎儿结构异常的胎儿生长受限且CMA或核型分析阴性的研究,以阴性CMA或核型结果为参照标准。
- 共纳入8项报告外显子组测序诊断率数据的研究,包括146例孤立性胎儿生长受限胎儿。
主要发现
- 146例孤立性胎儿生长受限胎儿中,17例检出判定为可能致病的致病性变异,外显子组测序合并增量诊断率为12%(95%CI:7%-18%)。
- 纳入研究的胎儿绝大多数在32周前接受评估。
关键数值与推荐
- 仅纳入分类为可能致病或致病且判定为导致胎儿表型的阳性变异。
- 以阴性CMA或核型分析结果作为参照标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this study was to determine the diagnostic yield of exome sequencing (ES) above that of chromosomal microarray analysis (CMA) or karyotyping in fetuses with isolated fetal growth restriction (FGR). This was a systematic review conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Selected studies included those with (a) only fetuses with FGR in the absence of fetal structural anomalies and (b) negative CMA or karyotyping results. Only positive variants classified as likely pathogenic or pathogenic determined as causative of the fetal phenotype were considered. A negative CMA or karyotype result was treated as the reference standard. Eight studies with data on ES diagnostic yield, including 146 fetuses with isolated FGR, were identified. Overall, a pathogenic variant determined as potentially causative of the fetal phenotype was found in 17 cases, resulting in a 12% (95% CI: 7%-18%) incremental performance pool of ES. The vast majority were studied before 32 weeks'gestation. In conclusion, a monogenic disorder was prenatally found in association with apparently isolated FGR in 12% of these fetuses.
引用
- Pauta M, Martinez-Portilla RJ, Meler E, et al. Diagnostic yield of exome sequencing in isolated fetal growth restriction: Systematic review and meta-analysis. Prenat Diagn. 2023. PMID: 36869857. doi:10.1002/pd.6339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。